Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Relapsing Polychondritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jing He, MD and PhD) · hejing1105@gmail.com · +8618611707347

Study leads

Zhanguo Li
Principal Investigator
Peking University Institute of Rheuamotology and Immunology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Relapsing Polychondritis

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Takayasu's Arteritis · Giant Cell Arteritis · Polyarteritis Nodosa

Abroad (travel likely)Recruiting

Bethesda, United States

Longitudinal Study for Relapsing Polychondritis

Relapsing Polychondritis · Vasculitis

Abroad (travel likely)Recruiting

Philadelphia, United States